Literature DB >> 23523972

Allogeneic Th1 cells home to host bone marrow and spleen and mediate IFNγ-dependent aplasia.

Joseph H Chewning1, Weiwei Zhang, David A Randolph, C Scott Swindle, Trenton R Schoeb, Casey T Weaver.   

Abstract

Bone marrow graft failure and poor graft function are frequent complications after hematopoietic stem cell transplantation and result in significant morbidity and mortality. Both conditions are associated with graft-versus-host disease (GVHD), although the mechanism remains undefined. Here we show, in 2 distinct murine models of GVHD (complete MHC- and class II-disparate) that mimic human peripheral blood stem cell transplantation, that Th1 CD4(+) cells induce bone marrow failure in allogeneic recipients. Bone marrow failure after transplantation of allogeneic naïve CD4(+) T cells was associated with increased CD4(+) Th1 cell development within bone marrow and lymphoid tissues. Using IFNγ-reporter mice, we found that Th1 cells generated during GVHD induced bone marrow failure after transfers into secondary recipients. Homing studies demonstrated that transferred Th1 cells express CXCR4, which was associated with accumulation within bone marrow and spleen. Allogeneic Th1 cells were activated by radiation-resistant host bone marrow cells and induced bone marrow failure through an IFNγ-dependent mechanism. Thus, allogeneic Th1 CD4(+) cells generated during GVHD traffic to hematopoietic sites and induce bone marrow failure via IFNγ-mediated toxicity. These results have important implications for prevention and treatment of bone marrow graft failure after hematopoietic stem cell transplantation.
Copyright © 2013 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23523972      PMCID: PMC3683565          DOI: 10.1016/j.bbmt.2013.03.007

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  53 in total

1.  T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia.

Authors:  Elena E Solomou; Keyvan Keyvanfar; Neal S Young
Journal:  Blood       Date:  2006-01-24       Impact factor: 22.113

Review 2.  Intracellular mediators of CXCR4-dependent signaling in T cells.

Authors:  Laura Patrussi; Cosima T Baldari
Journal:  Immunol Lett       Date:  2007-11-20       Impact factor: 3.685

3.  The sensitivity of human mesenchymal stem cells to ionizing radiation.

Authors:  Miao-Fen Chen; Ching-Tai Lin; Wen-Cheng Chen; Cheng-Ta Yang; Chih-Cheng Chen; Shuen-Kuei Liao; Jacqueline Ming Liu; Chang-Hsien Lu; Kuan-Der Lee
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-07-12       Impact factor: 7.038

4.  Graft-vs-leukemia activity and graft-vs-host disease induced by allogeneic Th1- and Th2-type CD4+ T cells in mice.

Authors:  M Zeis; L Uharek; G Hartung; B Glass; J Steinmann; N Schmitz
Journal:  Hematol J       Date:  2001

5.  A distal conserved sequence element controls Ifng gene expression by T cells and NK cells.

Authors:  Robin D Hatton; Laurie E Harrington; Rita J Luther; Therese Wakefield; Karen M Janowski; James R Oliver; Roger L Lallone; Kenneth M Murphy; Casey T Weaver
Journal:  Immunity       Date:  2006-10-26       Impact factor: 31.745

6.  Interferon-gamma regulates idiopathic pneumonia syndrome, a Th17+CD4+ T-cell-mediated graft-versus-host disease.

Authors:  Nora Mauermann; Julia Burian; Christophe von Garnier; Stefan Dirnhofer; Davide Germano; Christine Schuett; Michael Tamm; Roland Bingisser; Urs Eriksson; Lukas Hunziker
Journal:  Am J Respir Crit Care Med       Date:  2008-05-29       Impact factor: 21.405

7.  Elevation of intracellular cyclic AMP in alloreactive CD4(+) T Cells induces alloantigen-specific tolerance that can prevent GVHD lethality in vivo.

Authors:  Matthew J O'Shaughnessy; Zong-Ming Chen; Irene Gramaglia; Patricia A Taylor; Angela Panoskaltsis-Mortari; Christine Vogtenhuber; Ed Palmer; Thomas Grader-Beck; Vassiliki A Boussiotis; Bruce R Blazar
Journal:  Biol Blood Marrow Transplant       Date:  2007-05       Impact factor: 5.742

8.  IFNgamma differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract.

Authors:  Angela C Burman; Tatjana Banovic; Rachel D Kuns; Andrew D Clouston; Amanda C Stanley; Edward S Morris; Vanessa Rowe; Helen Bofinger; Renae Skoczylas; Neil Raffelt; Olivier Fahy; Shaun R McColl; Christian R Engwerda; Kelli P A McDonald; Geoffrey R Hill
Journal:  Blood       Date:  2007-04-20       Impact factor: 22.113

9.  Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10.

Authors:  Craig L Maynard; Laurie E Harrington; Karen M Janowski; James R Oliver; Carlene L Zindl; Alexander Y Rudensky; Casey T Weaver
Journal:  Nat Immunol       Date:  2007-08-12       Impact factor: 25.606

10.  Graft-versus-host disease causes failure of donor hematopoiesis and lymphopoiesis in interferon-gamma receptor-deficient hosts.

Authors:  Jean-Sébastien Delisle; Louis Gaboury; Marie-Pier Bélanger; Eliane Tassé; Hideo Yagita; Claude Perreault
Journal:  Blood       Date:  2008-06-13       Impact factor: 22.113

View more
  5 in total

1.  Human gingiva tissue-derived MSC ameliorates immune-mediated bone marrow failure of aplastic anemia via suppression of Th1 and Th17 cells and enhancement of CD4+Foxp3+ regulatory T cells differentiation.

Authors:  Jianzhi Zhao; Jingrong Chen; Feng Huang; Julie Wang; Wenru Su; Jianyao Zhou; Quanyin Qi; Fenglin Cao; Baoqing Sun; Zhongmin Liu; Joseph A Bellanti; Songguo Zheng
Journal:  Am J Transl Res       Date:  2019-12-15       Impact factor: 4.060

Review 2.  The complex and central role of interferon-γ in graft-versus-host disease and graft-versus-tumor activity.

Authors:  Hui Wang; Yong-Guang Yang
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

Review 3.  Clinical features, pathophysiology, and therapy of poor graft function post-allogeneic stem cell transplantation.

Authors:  Ashvind Prabahran; Rachel Koldej; Lynette Chee; David Ritchie
Journal:  Blood Adv       Date:  2022-03-22

Review 4.  Immunological Basis of Bone Marrow Failure after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Stavroula Masouridi-Levrat; Federico Simonetta; Yves Chalandon
Journal:  Front Immunol       Date:  2016-09-16       Impact factor: 7.561

Review 5.  Restoring T Cell Homeostasis After Allogeneic Stem Cell Transplantation; Principal Limitations and Future Challenges.

Authors:  Moutuaata M Moutuou; Gabriel Pagé; Intesar Zaid; Sylvie Lesage; Martin Guimond
Journal:  Front Immunol       Date:  2018-06-18       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.